Cetera Investment Advisers’s Onconetix ONCO Stock Holding History

Cetera Investment Advisers’s Portfolio ONCO Stock Details ONCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$53.5K	–	3863
2024 Q2	$53.5K	Hold	2	–	–	﹤0.01%	3589
2024 Q1	$49.3K	Buy	+2	New	+$60.9K	﹤0.01%	3570

Other funds holding ONCO

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cetera Investment Advisers's ONCO Position: Q3 2024 in Review

Cetera Investment Advisers sold out of Onconetix (ONCO) in Q3 2024, closing a stake of 2 shares — an estimated $53.5K sold.

Cetera Investment Advisers first reported a position in ONCO in Q1 2024 and held it in 2 quarters. The position peaked at $53.5K in Q2 2024. 5 funds tracked by Wall St. Rank hold ONCO as of Q3 2024.

Cetera Investment Advisers reported no remaining Onconetix position as of Q3 2024 after selling out during the quarter.
Cetera Investment Advisers sold 2 Onconetix shares in Q3 2024, an estimated $53.5K.
Cetera Investment Advisers first reported a position in Onconetix in Q1 2024 and held it in 2 quarters.
Cetera Investment Advisers's Onconetix position peaked at $53.5K in Q2 2024.
5 funds tracked by Wall St. Rank held Onconetix as of Q3 2024.

Based on Cetera Investment Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.